Utah All Payer Database (APD) Introduction to the Reporting Capabilities of the Utah All Payer Database Mark Gaskill, MFT Keely Cofrin.

Slides:



Advertisements
Similar presentations
Barbara Rudolph, PhD, MSSW NAHDO Consultant. To enhance the value of statewide APCDs by cataloging measures and reporting practices To develop and disseminate.
Advertisements

Pilgrimage Healthcare Patients Deserve More Options…
Medicare and Medicaid Drug Payments for Medicare Only and Medicare/Medicaid Dual Eligible Populations APHA Conference Washington, DC November 2, 2011.
Copyright ©2011 Freedman Healthcare, LLC All Payer Claims Datasets: Big Data is Coming to Public Health Officials, Providers and Patients Near You StrataRx.
Department of Vermont Health Access Vermont Blueprint for Health: Using APCD to Evaluate Health Care Reform Pat Jones, MS Blueprint Assistant Director.
PEBB Disease Burden Report PEBB Board of Directors August 21, 2007 Bdattach.10.
HFMA December Attacking Rising Costs 23% of the Medicare population has a chronic condition with 5 or more co-morbid conditions that compel them.
Wellness Curriculum: Teaching Inmates to Take Care of Their Health Yolanda G. Martinez, Ph.D. Office of Minority Health Orange County Health Department.
Planning, Public Policy & Management The University of Oregon Consumer Driven Health Care Summit September 14, 2006 Funded by Changes in Health Care Financing.
Integrated Physical & Behavioral Health
Access Health Closing the Gap Between Public and Private Insurance Coverage.
Payment and Delivery Reform: Building a Bridge to the Future
1 Healthcare: Linking Return to Work with Healthcare Outcomes to Lower Costs Barton Margoshes, MD Chief Medical Officer CIGNA Group Insurance.
Measuring the Quality of Pennsylvania’s Commercial HMOs Joe Martin Director of Communications and Education Pennsylvania Health Care Cost Containment Council.
Impact of the MMA on Existing Disease Management Programs and Managed Care Initiatives for the Aged and Disabled Center for State Health Policy Rutgers,
Agency for Healthcare Research and Quality Advancing Excellence in Health Care Provision of Preventive Services in the Complex Patient AHRQ.
The Business Case for Bidirectional Integrated Care: Mental Health and Substance Use Services in Primary Care Settings and Primary Care Services in Specialty.
An Overview of NCQA’s Relative Resource Use Measures.
Harnessing the Power of Predictive Modeling Future Trends.
Snapshot of IMS LifeLink Claims Database 10% Random Sample
Microsoft’s Wellness & Weight Management Programs December 14, 2005 Tom McPherson Senior Benefits Manager.
Page 1 Overview of Self-Funded Health Plans a step ahead McNeary, Inc.
UMSYSTEM.EDU November 19, UMSYSTEM.EDU Missouri S&T Faculty Senate November 19, 2009.
July 31, 2009Prepared by the Maine Health Information Center Overview of All Payer Claims Data Suanne Singer, Senior Consultant Maine Health Information.
© 2011 Blue Cross and Blue Shield of Minnesota. All rights reserved. The Role of Payment Reform in the Transformation of the HealthCare System Jim Eppel.
Partnering with Affordable Care Organizations Vernice Davis Anthony Greater Detroit Area Health Council President and CEO October 13, 2011.
City of Phoenix Retiree Medical Coverage Overview COPRA Meeting May 21, 2009.
1 Institute for Population and Social Research (IPSR) FACTORS AFFECTING HEALTHCARE EXPENDITURE OF THE THAI ELDERLY Danusorn Potharin 1 and Wathinee Boonchalaksi.
2006 Drug Trend Julayna Meyer, R.Ph, MBA Vice President Trend Management.
Title Slide Sub Title The Health Collaborative: Current Activities and Capabilities July 13, 2012 Greg Ebel, Executive Director Melissa Kennedy, Director.
LOCKTON DUNNING BENEFITS UNIVERSITY OF ALASKA 2ND QTR FY13 UTILIZATION REVIEW 7/1/2012 TO 12/31/2012.
L.A. Care Health Plan Behavioral Health Support Services E.E. Lazarou, MD, MS, RD Health Integrated.
Payment and Delivery Reform Steve Arner Senior Vice President / Chief Operating Officer June 6, 2013.
Quality & Service Recognition Program A PPO Incentive Program for Quality Richard S. Chung, MD SVP, Health Services Division BCBS of Hawaii (Hawaii Medical.
BlueCross BlueShield of Tennessee, Inc., an Independent Licensee of the BlueCross BlueShield Association. This document has been classified as public Information.
Click to edit Master subtitle style Aetna Behavioral Health Depression Initiatives June 2006.
An Electronic Dashboard For Improving the Quality of Health Care and for Decreasing the Cost of health Care Stephen A. Kardos D.O.
1 © Copyright Life Insurance Company of North America 2005 Intervention & Preventative Programs to Reduce Healthcare Costs Barton Margoshes, MD Chief Medical.
State Employee Health Insurance Virginia Department of Human Resource Management Senate Finance Committee General Assembly Building, Richmond, Virginia.
1 Soyal Momin MS, MBA December 14 th, 2007 Maximizing the Value of Predictive Modeling: The BlueCross BlueShield of Tennessee Experience.
K ENTUCKY Cabinet for Health and Family Services Kentucky Department for Medicaid Services Lisa D. Lee, Commissioner November 20, 2015.
Uses of NH’s Claims Database: Comprehensive Health Care Information System (CHIS) Christine Shannon Office of Medicaid Business & Policy, NH DHHS July.
2007 Drug Trend Brian Seiz, PharmD Express Scripts.
The Effect of Consumer Driven Health Plans on Pharmaceutical Cost & Use: Do 3-Tier Plans Have a Competitor? Stephen T Parente Jon B Christianson Roger.
NAHDO Annual Conference; October 2009 Patrick Miller, MPH; Research Associate Professor Jo Porter, MPH; Deputy Director NH Institute for Health Policy.
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015 Average annual growth rate of prescription drug spending per capita.
Evaluation of Virginia’s Preferred Drug List: 4th Quarter Report Policy and Research Division November 2, 2004Department of Medical Assistance Services.
Source: National Association of Health Underwriters Education Foundation State of U.S. Healthcare 1.
Department of Public Health Medically Indigent Care Reporting System (MICRS) Medically Indigent Services Program (MISP) 1.
Confidential and Proprietary Information © 2012 Express Scripts, Inc. All Rights Reserved 1 AGING-RELATED MEDICATIONS: COST AND UTILIZATION PATTERNS Presenter:
Peterson-Kaiser Health System Tracker What are the recent and forecasted trends in prescription drug spending?
Private Insurance Payers and Plans Chapter 3
Wireless Access SSID: cwag2017
Strategies to Modernize State Medicaid Programs, Utah’s Medicaid Transformation By Lisa V. Hulbert R.Ph. Transformation Program Manager Utah Medicaid.
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015
TOTAL HEALTH INSIGHT Powered by Consultative AnalyticsSM
Chapter 7: Prescription Drug Coverage in Patients with CKD
MHQP Executive Director Pay for Performance Summit
Chapter 10: Prescription Drug Coverage in Patients with ESRD
Total U.S. prescription drug spending, in $ billions:
IBH, Cost (Risk Adjusted)
Utah’s APCD as a Stand-alone Opioid Monitoring Tool
CCIC 2018 Member Forum Using Data to Reduce Costs and Improve Health
Addiction Why It’s YOUR Business
Chapter 8: Prescription Drug Coverage in Patients with CKD
Chapter 10: Prescription Drug Coverage in Patients with ESRD
Growth in prescription spending had slowed, but increased rapidly in 2014 and 2015
Two of Five Insured Adults with Incomes Below the Federal Poverty Level Spent 5 Percent or More of Their Income on Medical Out-of-Pocket Costs Percent.
High Chronic Disease Burden Among U.S. Women
Treated Chronic Disease Cost in MN: A Look Back & a Look Forward
Presentation transcript:

Utah All Payer Database (APD) Introduction to the Reporting Capabilities of the Utah All Payer Database Mark Gaskill, MFT Keely Cofrin Allen, PhD Utah Department of Health Office of Health Care Statistics

History On July 8, 2008 the Utah Health Data Committee unanimously approved a health data plan outlining the creation of an APD. Funding for the APD was provided via House Bill 133, Health Care Reform (2008). The Utah Department of Health (UDOH), Office of Health Care Statistics (OHCS) is responsible for building and managing the APD. Other states have APDs; however, Utah is now the first state in the country to have an All Payer Database that can analyze episodes of care (EOC) derived from statewide – cross payer – health insurance claims.

The Utah APD now provides the capability of reporting: Medically, what happened? (by EOC) When and where did it happen? How much did it cost? Greater Degrees of Healthcare Transparency Who paid for what (including healthcare consumer out of pocket costs)? Which costs were not covered? (including denied claims) What other influences impact outcome (disease burden, co-morbidities, demographics, environmental issues, access to specialists, etc.)? What impact does preventive care or lack there of, have on outcome? Were relevant standards of care met? How do healthcare consumers migrate between commercial plans; between commercial and public plans?

Where the Utah APD Stands Today: $1,847,869,396 - Utah Health Care Dollars Represented in the Utah APD 1,079,270 - Unique Utah lives identified, linked and grouped 48,567,000- Medical Claims processed and parsed in the APP primary data warehouse 67,989,000 - Pharmacy Claims process and parsed in the APD primary data warehouse Second Phase Pilot will be competed February 2010 (initial APD reporting will commence during Second Phase Pilot); Third Phase Pilot Completed Summer 2010 (APD fully operational)

Top Ten Diseases Driving Cost Analysis Period Ending: DiseaseNumber of Members *Percent of TotalTotal CostPercent of Total Cost 1Diabetes17, %$99,704, % 2Hypertension23, %$55,667, % 3Asthma11, %$34,677, % 4CAD2, %$27,548, % 5Breast Cancer1, %$18,016, % 6Depression14, %$16,423, % 7ESRD %$14,951, % 8CVA1, %$14,416, % 9CHF %$8,154, % 10COPD %$6,699, % * Unique members with the disease

Top Five Conditions Driving Cost DiseaseNumber of Members * Percent of Total Members Total Paid Claims Percent of Total Paid Claims 1Healthy320, %$84,501, % 2Cancer6, %$77,252, % 3Cardiac22, %$68,180, % 4Psychiatric24, %$63,062, % 5GU21, %$56,900, % Other 35, %$160,163, %

Top Ten Therapeutic Classes by Volume Therapeutic ClassTotal Cost Utilizing Members Script PMPY Cost Per Member Number of Scripts Average Cost Per Script Percent Generic 1*ANTIDEPRESSANTS*$13,759,11164, $593389,494$3576 % 2*ANALGESICS - OPIOID*$7,247,71792, $440334,445$2297 % 3*ULCER DRUGS*$17,308,65642, $1,466192,155$9048 % 4*ANTIHYPERLIPIDEMICS*$10,809,47633, $948181,827$5957 % 5*CONTRACEPTIVES*$3,953,77134, $360173,187$2356 % 6*ANTIHYPERTENSIVES*$5,536,94030, $500170,152$3358 % 7*PENICILLINS*$980,075100, $87154,660$699 % 8*ANTIDIABETICS*$12,798,76219, $1,723141,974$9050 % 9*THYROID AGENTS*$1,424,25727, $155140,098$1097 % 10*DERMATOLOGICALS*$6,360,40366, $760139,962$4566 %

Top Ten Therapeutic Classes by Cost Therapeutic ClassTotal Cost Utilizing Members Script PMPY Cost Per Member Number of Scripts Average Cost Per Script Percent Generic 1*ULCER DRUGS*$17,308,65642, $1,466192,155$9048 % 2*ANTIDEPRESSANTS*$13,759,11164, $593389,494$3576 % 3*ANTIDIABETICS*$12,798,76219, $1,723141,974$9050 % 4*ANTIHYPERLIPIDEMICS*$10,809,47633, $948181,827$5957 % 5*ANTICONVULSANTS*$10,086,37919, $1,538112,157$9052 % 6 *ANTIASTHMATIC AND BRONCHODILATOR AGENTS* $8,438,79935, $1,231121,808$6920 % 7 *ADHD/ANTI-NARCOLEPSY/ANTI- OBESITY/ANOREXIANTS* $7,563,89720, $1,128102,857$7434 % 8*ANTIPSYCHOTICS*$7,371,7487, $3,29842,410$17419 % 9*ANALGESICS - OPIOID*$7,247,71792, $440334,445$2297 % 10*DERMATOLOGICALS*$6,360,40366, $760139,962$4566 %

Pharmacy Statistics Scripts PMPY Average Cost PMPY Brand Percent by Volume Generic Percent by Volume Brand Cost PMPYGeneric Cost PMPY 9.7$40628 %72 %$281$124 Top Twenty Drugs by Cost - Retail NameTotal CostUtilizing MembersTotal ScriptsCost Per ScriptCost Per Member 1Prevacid$4,546,6708,38142,510$107$10 2Oxycodone Hcl$3,064,2683,07823,522$130$7 3Aciphex$2,860,9934,12823,903$120$6 4Valtrex$2,705,6837,13716,994$159$6 5Seroquel$2,655,2972,61515,837$168$6 6Advair Diskus$2,634,0165,63818,955$139$6 7Amphetamine Salt Combo$2,587,3545,31333,276$78$6 8Venlafaxine Hcl$2,549,3704,27531,737$80$6 9Topamax$2,468,8242,52413,647$181$5 10Novolog$2,425,1642,72915,267$159$5 11Cymbalta$2,389,7884,37227,409$87$5 12Testosterone$2,251,4432,79113,288$169$5 13Provigil$2,051,1141,90811,365$180$4 14Lamotrigine Chewable Dispersible$1,961,5552,44112,352$159$4 15Abilify$1,863,6461,2746,254$298$4 16Imitrex$1,846,4562,72913,340$138$4 17Singulair$1,729,0446,35126,582$65$4 18Isotretinoin$1,669,0391,7717,172$233$4 19Methylphenidate Hcl$1,667,5144,15826,157$64$4 20Lovenox$1,493,5151,0242,657$562$3

Generic Utilization Total Prescriptions

Average MembershipPercent of TotalTotal PaidPercent of Total PaidAverage PMPM Paid Healthy1272, %$121,033, %$37 One or More Significant Acute Diseases231, %$80,806, %$215 One Minor Chronic Disease347, %$72,885, %$128 Multiple Minor Chronic Diseases416, %$49,025, %$245 One Significant Chronic Disease555, %$163,910, %$247 Two Significant Chronic Diseases635, %$276,306, %$648 Three or More Significant Chronic Diseases71, %$28,821, %$1,582 Complicated Malignancies81, %$51,385, %$3,023 Catastrophic Conditions91, %$36,522, %$3,002 Total 462,915 $880,698,138 $159 Health Status and Cost Drivers

Average PMPM Distribution by Health Status

Member Distribution and BOI by Demographics and Age Average MembershipAverage Cost PMPMAverage Burden of Illness Total462,915$ Male231,621$ ,988$ ,797$ ,187$ ,342$ ,398$ ,001$ ,185$ ,723$ Female231,294$ ,142$ ,074$ ,754$ ,138$ ,459$ ,666$ ,898$ ,164$

Top Twenty-Five Drugs by Volume - Retail NameTotal CostUtilizing MembersTotal ScriptsCost Per ScriptCost Per Member 1Acetaminophen/hydrocodone$333,83959,439177,855$2$1 2Amoxicillin$272,88471,020100,836$3$1 3L-Thyroxine Sodium$451,57313,67881,720$6$1 4Azithromycin$488,68448,29768,057$7$1 5Acetaminophen/oxycodone$669,82425,08455,838$12$1 6Omeprazole$538,80815,30654,633$10$1 7Citalopram Hydrobromide$70,26612,39854,379$1$0 8Simvastatin$81,27311,75052,936$2$0 9Child Ibuprofen$152,46330,71852,843$3$0 10Alprazolam$109,33511,24348,232$2$0 11Fluoxetine Hcl$170,90210,20548,180$4$0 12Sertraline Hcl$111,2579,46345,171$2$0 13Prevacid$4,546,6708,38142,510$107$10 14Metformin Hcl$107,7128,14237,217$3$0 15Bupropion Er$1,272,7778,06435,854$35$3 16Amphetamine Salt Combo$2,587,3545,31333,276$78$6 17Amoxicillin/clavulanate Potassium$547,40924,59232,095$17$1 18Yasmin 28$872,7817,40731,844$27$2 19Venlafaxine Hcl$2,549,3704,27531,737$80$6 20Fluconazole$37,04713,37031,596$1$0